MedPath

NP Thyroid 90

NP Thyroid 90

Approved
Approval ID

bc6c190c-e813-4fff-b8aa-4848d45a8143

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jun 7, 2023

Manufacturers
FDA

RPK Pharmaceuticals, Inc.

DUNS: 147096275

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

LEVOTHYROXINE, LIOTHYRONINE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code53002-5800
Product Classification
G
Generic Name
LEVOTHYROXINE, LIOTHYRONINE
Product Specifications
Route of AdministrationORAL
Effective DateApril 27, 2023
FDA Product Classification

INGREDIENTS (5)

MINERAL OILInactive
Code: T5L8T28FGP
Classification: IACT
LEVOTHYROXINEActive
Quantity: 57 ug in 1 1
Code: Q51BO43MG4
Classification: ACTIB
LIOTHYRONINEActive
Quantity: 13.5 ug in 1 1
Code: 06LU7C9H1V
Classification: ACTIB
CALCIUM STEARATEInactive
Code: 776XM7047L
Classification: IACT
DEXTROSE MONOHYDRATEInactive
Code: LX22YL083G
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

NP Thyroid 90 - FDA Drug Approval Details